Skadden, Arps, Slate, Meagher & Flom and Commerce & Finance Law Offices have counselled travel website Trip.com on its $1.09 billion secondary listing on the Hong Kong Stock Exchange, with Latham & Watkins and Jingtian & Gongcheng advising the joint sponsors and the underwriters.

China-headquartered Trip.com is the first travel platform to be listed on both the U.S. and Hong Kong stock markets.

According to Reuters, the company will sell 31.63 million shares, in the deal which represented 5 percent of its total outstanding shares

The listing comes as a spate of U.S.-listed Chinese companies opt for secondary listings in Hong Kong, including Bilibili, Autohome, New Oriental Education & Technology, Yum China Holdings, Zai Lab, ZTO Express and Huazhu Group.

The Latham & Watkins team was led by partners Terris Tang, Daying Zhang, Benjamin Su, Cathy Yeung, Alex Cohen, Paul Dudek, Dana Fleischman Simon Hawkins and Samuel Weiner.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com.

Related Articles

Deals

Skadden, Jia Yuan, Freshies, KWM act on Midea’s $3.5 bln HK share offering

by Asian Legal Business《亚洲法律杂志》 |

Skadden, Arps, Slate, Meagher & Flom and Jia Yuan Law Offices are advising Chinese home appliance maker Midea Group on its HK$26.97 billion ($3.46 billion) share offering in Hong Kong, the city's largest listing in more than three years.

Deals

Skadden, STB advise on Timee’s $435mln Japan IPO

by Nimitt Dixit |

U.S. law firm Skadden, Arps, Slate, Meagher & Flom has guided Timee, Inc, a Japanese on-demand job platform, on its $435 million initial public offering and listing on the Tokyo Stock Exchange. Simpson Thacher & Bartlett advised the international managers on the deal.

Deals

Skadden, Latham act on $1.1 bln Japan outbound pharma deal

by Asian Legal Business《亚洲法律杂志》 |

Skadden, Arps, Slate, Meagher & Flom has advised Japan's Otsuka Pharmaceutical on its $1.1 billion agreement to acquire Boston-based Jnana Therapeutics, which was represented by Latham & Watkins.